Source: Afriforum

The civil rights organisation AfriForum and Dr George Coetzee today achieved a further success in the fight for access to ivermectin when the settlement for the compounding of and access to ivermectin with the South African Health Products Regulatory Authority (SAHPRA) was made an order of court.

This court order determines that a medicine containing ivermectin as an active ingredient has been registered by SAHPRA on 16 March 2021. The effect of the registration is that ivermectin may be compounded and made accessible in accordance with the provisions of Section 14(4) of the Act.

The order also determines that access to imported ivermectin may be provided in accordance with the provisions of Section 21 of the Act. The order further determines that SAHPRA and the Minister of Health, jointly and severally, will pay a total contribution to the costs of the four applicant groups in the amount of R1,8 million (plus VAT).

Because a medicine that contains ivermectin as an active ingredient is now registered and ivermectin is listed as a schedule 3 substance, ivermectin can now be used for other purposes than stated on the label of the registered medicine (off-label use) – which includes the treatment of COVID-19.

“Access in accordance with Section 14(4) of the Act practically means that doctors can prescribe ivermectin on their own judgement and that no Section 21 application or reporting is required for compounded ivermectin. Patients can then use this prescription to buy ivermectin from any pharmacy where compounded ivermectin is available,” says Barend Uys, Head of Research at AfriForum.

“We are very glad that the settlement was made an order of court as this provides certainty for doctors and patients,” says Dr George Coetzee.

The order further determines that SAHPRA must report back to the court every three months about the state of affairs relating to ivermectin and that any party to the application may approach the court by way of a notice of motion and supplementary affidavits, for relief pertaining to any further aspects relating to the administration and allowance of the use of ivermectin as a treatment against COVID-19. This part of the order did not form part of the original settlements that was agreed to between the parties.

We also want to acknowledge the contribution of our excellent legal team, Dr George Coetzee and other stakeholders like the Pharma Valu pharmacy group, the ‘I can make a difference’ doctors group and the ACDP that worked with dedication to ensure accessibility to ivermectin for citizens.

Related: The lawyer who won the Ivermectin battle for South Africans

Ivermectin for Prevention and Treatment of COVID-19 Infection: a Systematic Review and Meta-analysis

HCQ and Ivermectin included in multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk COVID-19

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk COVID-19 infection includes HCQ & Ivermectin

‘We think that Ivermectin can help break Covid transmission chains, says Prof Schwartz, Israel

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »